October 2012 | Cardiovascular Business

Future of CV Innovation: The World is Flattening

Multiple factors thwart the efforts to bring new technologies to patients suffering from cardiovascular disease. Regulatory barriers, less financial return on investment and government impediments interfere with innovation. However, if innovators can adapt and evolve to the flattening of the global healthcare setting, a silver lining may materialize

When Hospitals Say I do to TAVR

Providers offering this new therapy may require extra resources, but pioneers and relative newcomers agree that it has its rewards.

Redefining PAD with a Feminine Touch

Efforts to better identify asymptomatic peripheral artery disease (PAD) may allow for earlier diagnosis and intervention especially for women, in whom the disease burden may be higher.

Birth of PERT: Systematic Approach to Acute PE

Due to a lack of clarity and uniformity in how to diagnose and treat acute pulmonary emboli (PE), one hospital is taking steps to standardize care.

Carotid Conundrum: Role of Ultrasound Screening

Despite recommendations to the contrary, screening for carotid artery stenosis remains prevalent. Check out the pros and cons.

Understanding the Valuation of Your Practice

Practices need to better understand their worth before they get to the negotiating table with a hospital. Here are some tips.

ACC Corner | Cardio-Metabolic Syndrome: Insights & Opportunities Abound

With the prevalence of metabolic syndrome increasing, the cardiovascular field has been challenged with educational and research opportunities to build awareness and learn more about this growing health problem.

Select an Issue